You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
复星医药与BioNTech疫苗周六抵港
阿思达克 03-01 09:11
复星医药(02196.HK)与BioNTech(BNTX.US)公布,首批mRNA新冠疫苗复必泰於上周六(2月27日)由德国法兰克福机场出发,并已顺利抵达中国香港国际机场。该批疫苗将分别供应香港及澳门地区,供应澳门的疫苗将从香港国际机场经由港珠澳大桥转运至澳门。

复星医药董事长兼首席执行官吴以芳表示,将密切配合香港和澳门特别行政区政府的疫苗接种计划,巩固港澳疫情防控成果。BioNTech首席执行官兼联合创始人Ugur Sahin表示,将确保复必泰能顺利在香港推出,也将继续致力为全球各个地区提供高耐受性和有效性的疫苗。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account